Komori
Dreambed (7791) · FactDecrease in R&D expenses

Research and Development Expenditure

First written in FY2022-Q3. . Latest entry: FY2026.

14entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2022-Q3 – FY20262022: 420222023: 420232024: 320242025: 220252026: 12026
Same theme, other companies
Decline in R&D spendingA theme 50 companies write about · 46 as a headwind · 4 as a tailwind

42 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2026Decrease in R&D expensesAnnual report

    「Total R&D expenditure for the fiscal year was ¥78 million.」

    R&D expenditure decreased from ¥105.506 million in the previous fiscal year to ¥78.985 million.
  2. FY2026-H1Decrease in R&D expensesAnnual report

    「The amount spent on the company's R&D activities during the interim accounting period was ¥36 million.」

    R&D spending was ¥36 million, down from approximately ¥54 million in the same period of the previous fiscal year.
  3. FY2025Increase in R&D expensesAnnual report

    「Total R&D expenditure for the fiscal year was ¥105.506 million.」

    R&D expenditure increased from ¥78.572 million in the previous fiscal year to ¥105.506 million. The company developed products for trade shows and Dream Refine events, OEM products, and licensed-manufactured products adapted to Japanese specifications.
  4. FY2025-H1Higher Research and Development Expenses for the Interim PeriodAnnual report

    「The amount spent on the company's R&D activities during the interim accounting period was ¥54 million.」

    R&D spending was ¥54 million, up from approximately ¥39.9 million in the same period of the previous fiscal year.
  5. FY2024R&D expenditure increased; new product development expandedAnnual report

    「Total R&D expenditure for the fiscal year was ¥78.572 million.」

    R&D expenditure increased from ¥66.163 million in the previous fiscal year to ¥78.572 million. The company developed products for trade shows, OEM products, and products manufactured under license adapted to Japanese specifications.
  6. FY2024-Q3Increase in R&D expenses for the first 3 quartersAnnual report

    「The amount spent on the company's R&D activities during the nine months ended December 31 was ¥61.183 million.」

    R&D spending for the nine months ended December 31 was ¥61.183 million, up from ¥52.487 million in the same period of the previous fiscal year.
  7. FY2024-Q2First-half R&D expenditure increasedAnnual report

    「The amount spent on the company's R&D activities during the six months ended September 30 was ¥39.904 million.」

    R&D spending for the first half was ¥39.904 million, up from ¥33.030 million in the same period of the previous fiscal year.
  8. FY2024-Q1First-quarter R&D expenditure declinedAnnual report

    「The amount spent on the company's R&D activities during the three months ended June 30 was ¥17.727 million.」

    R&D spending for the first quarter was ¥17.727 million, down from ¥18.732 million in the same period of the previous fiscal year.
  9. FY2023Increase in R&D expensesAnnual report

    「Total R&D expenditure for the fiscal year was ¥66.163 million.」

    R&D expenditure increased from ¥62.249 million in the previous fiscal year to ¥66.163 million.
  10. FY2023-Q3Increase in R&D expenses for the first 3 quartersAnnual report

    「The amount spent on the company's R&D activities during the nine months ended December 31 was ¥52.487 million.」

    R&D spending for the nine months ended December 31 was ¥52.487 million, up from ¥33.030 million in the six months ended September 30 of the previous fiscal year.
  11. FY2023-Q2First-half R&D expenditure disclosedAnnual report

    「The amount spent on the company's R&D activities during the six months ended September 30 was ¥33.030 million.」

    The company disclosed R&D spending of ¥33.030 million for the six months ended September 30.
  12. FY2023-Q1First-quarter R&D expenditure disclosedAnnual report

    「The amount spent on the company's R&D activities during the three months ended June 30 was ¥18.732 million.」

    The company disclosed R&D spending of ¥18.732 million for the three months ended June 30.
  13. FY2022Increase in R&D expensesAnnual report

    「Total R&D expenditure for the fiscal year was ¥62.249 million.」

    R&D expenditure was ¥62.249 million, exceeding ¥48.551 million in the nine months ended December 31 of the previous fiscal year and ¥52.118 million in the previous fiscal year.
  14. FY2022-Q3First statedAnnual report

    「The amount spent on the company's R&D activities during the nine months ended December 31 was ¥48.551 million.」

    The company disclosed R&D spending of ¥48.551 million for the nine months ended December 31.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Dreambed yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and Development Expenditure | DREAMBED CO.,LTD. (7791) | Komori